Abingdon Health is a contract development and manufacturing organisation specialising in lateral flow rapid diagnostic tests.
It provides end-to-end services spanning assay development, scale-up manufacturing, regulatory approval and commercialisation support across healthcare, animal health and plant health.
The company operates manufacturing facilities in York and Doncaster and also provides regulatory and analytical testing services through specialist divisions.
Latest News
Abingdon Health's Doncaster Laboratory Gains ISO/IEC 17025 Accreditation
Abingdon Health's subsidiary Abingdon Analytical has received ISO/IEC 17025:2017 accreditation from UKAS for its Doncaster performance evaluation laboratory, its first. The lab provides testing that diagnostics developers include in UKCA, EU IVDR and FDA regulatory submissions.
Abingdon Health Reports FY26 Revenue Up 31%, Reaches H2 EBITDA Profitability
Abingdon Health expects FY26 revenue up 31% to £11.3m, driven by a strong second half that was 63% ahead of H1 on higher contract development and R&D income. The company reached adjusted EBITDA profitability in H2 and ended the year with £2.9m cash, with the board citing previously secured CDMO contracts as the foundation for further growth in FY27.